Ratings by Citi (Joel Beatty)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/12/2021 | Alnylam Pharmaceuticals | ALNY | Downgrade | Neutral (Buy) |
165.38 (300.71) |
81.83% | Details | |
| 2/11/2021 | Vanda Pharmaceuticals | VNDA | Maintain | Neutral (N/A) |
|
Details | ||
| 1/15/2021 | DBV Technologies S.A | DBVT | Maintain | Buy (N/A) |
|
Details | ||
| 1/14/2021 | Vanda Pharmaceuticals | VNDA | Downgrade | Neutral (Buy) |
14.16 (5.95) |
-57.98% | Details | |
| 1/12/2021 | Sarepta Therapeutics | SRPT | Downgrade | Neutral (Buy) |
89.76 (17.16) |
-80.88% | Details | |
| 1/8/2021 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 1/5/2021 | PTC Therapeutics | PTCT | Upgrade | Buy (Neutral) |
60.50 (84.38) |
39.47% | Details | |
| 12/29/2020 | Eidos Therapeutics | EIDX | Maintain | Neutral (N/A) |
|
Details | ||
| 12/21/2020 | NGM Biopharmaceuticals | NGM | Maintain | Buy (N/A) |
|
Details | ||
| 12/14/2020 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 12/11/2020 | Halozyme Therapeutics | HALO | Maintain | Neutral (N/A) |
|
Details | ||
| 11/30/2020 | CymaBay Therapeutic | CBAY | Maintain | Buy (N/A) |
|
Details | ||
| 10/30/2020 | PTC Therapeutics | PTCT | Downgrade | Neutral (Buy) |
53.89 (84.38) |
56.58% | Details | |
| 10/29/2020 | Vanda Pharmaceuticals | VNDA | Upgrade | Buy (Neutral) |
10.59 (14.16) |
33.71% | Details | |
| 10/7/2020 | Eidos Therapeutics | EIDX | Downgrade | Neutral (Buy) |
73.51 (122.21) |
66.25% | Details | |
| 10/5/2020 | Amarin Corporation | AMRN | Maintain | Buy (N/A) |
|
Details | ||
| 10/5/2020 | Amarin Corporation | AMRN | Maintain | Buy (N/A) |
|
Details | ||
| 9/18/2020 | Arena Pharma | ARNA | Maintain | Buy (N/A) |
|
Details | ||
| 9/15/2020 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 9/8/2020 | Ionis Pharmaceuticals | IONS | Maintain | Buy (N/A) |
|
Details | ||
| 9/8/2020 | Alnylam Pharmaceuticals | ALNY | New Coverage | Buy (N/A) |
125.19 (165.38) |
32.1% | Details | |
| 9/8/2020 | Eidos Therapeutics | EIDX | New Coverage | Buy (N/A) |
40.39 (122.21) |
202.57% | Details | |
| 9/1/2020 | Mirum Pharamceuticals | MIRM | Maintain | Buy (N/A) |
|
Details | ||
| 8/25/2020 | CymaBay Therapeutic | CBAY | Maintain | Buy (N/A) |
|
Details | ||
| 8/21/2020 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2020 | Halozyme Therapeutics | HALO | Maintain | Neutral (N/A) |
|
Details | ||
| 8/10/2020 | Amarin Corporation | AMRN | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2020 | Ionis Pharmaceuticals | IONS | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2020 | DBV Technologies S.A | DBVT | Maintain | Buy (N/A) |
|
Details | ||
| 7/27/2020 | Arena Pharma | ARNA | Maintain | Buy (N/A) |
|
Details | ||
| 6/30/2020 | Intercept Pharmaceuticals | ICPT | Upgrade | Buy (Neutral) |
46.70 (19.00) |
-59.31% | Details | |
| 6/29/2020 | Pliant Therapeutics | PLRX | New Coverage | Buy (N/A) |
31.08 (35.90) |
15.51% | Details | |
| 6/12/2020 | Halozyme Therapeutics | HALO | Maintain | Neutral (N/A) |
|
Details | ||
| 6/11/2020 | Eloxx Pharma | ELOX | Downgrade | Neutral (Buy) |
3.51 (12.05) |
243.3% | Details | |
| 6/9/2020 | Vanda Pharmaceuticals | VNDA | Downgrade | Neutral (Buy) |
11.46 (5.95) |
-48.08% | Details | |
| 6/5/2020 | Ionis Pharmaceuticals | IONS | Maintain | Buy (N/A) |
|
Details | ||
| 6/2/2020 | Ayala Pharmaceuticals | AYLA | New Coverage | Buy (N/A) |
15.70 (0.50) |
-96.82% | Details | |
| 6/1/2020 | Minerva Neurosciences | NERV | Maintain | Buy (N/A) |
|
Details | ||
| 5/22/2020 | Syndax Pharmaceuticals | SNDX | Upgrade | Buy (Neutral) |
20.50 (20.49) |
-0.05% | Details | |
| 5/18/2020 | Syndax Pharmaceuticals | SNDX | Downgrade | Neutral (Buy) |
20.98 (20.50) |
-2.29% | Details | |
| 5/18/2020 | X4 Pharmaceuticals | XFOR | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2020 | Intercept Pharmaceuticals | ICPT | Downgrade | Neutral (Buy) |
90.44 (46.70) |
-48.36% | Details | |
| 5/7/2020 | Esperion Therapeutics | ESPR | Maintain | Buy (N/A) |
|
Details | ||
| 5/1/2020 | Amarin Corporation | AMRN | Maintain | Buy (N/A) |
|
Details | ||
| 4/9/2020 | Ionis Pharmaceuticals | IONS | Maintain | Buy (N/A) |
|
Details | ||
| 4/9/2020 | PTC Therapeutics | PTCT | Upgrade | Buy (Neutral) |
42.79 (53.89) |
25.94% | Details | |
| 4/6/2020 | PhaseBio Pharmaceuticals Inc. | PHAS | Maintain | Buy (N/A) |
|
Details | ||
| 4/6/2020 | DBV Technologies S.A | DBVT | Maintain | Buy (N/A) |
|
Details | ||
| 3/31/2020 | Amarin Corporation | AMRN | Maintain | Buy (N/A) |
|
Details | ||
| 3/27/2020 | NGM Biopharmaceuticals | NGM | Maintain | Buy (N/A) |
|
Details | ||
| 3/26/2020 | X4 Pharmaceuticals | XFOR | Maintain | Buy (N/A) |
|
Details | ||
| 3/24/2020 | Millendo Therapeutics Inc. | MLND | Maintain | Buy (N/A) |
|
Details | ||
| 3/20/2020 | CymaBay Therapeutic | CBAY | Maintain | Buy (N/A) |
|
Details | ||
| 3/19/2020 | Mirum Pharamceuticals | MIRM | Maintain | Buy (N/A) |
|
Details | ||
| 3/19/2020 | FibroGen | FGEN | Maintain | Buy (N/A) |
|
Details | ||
| 3/19/2020 | FibroGen | FGEN | Maintain | Buy (N/A) |
|
Details | ||
| 3/17/2020 | Esperion Therapeutics | ESPR | Upgrade | Buy (Neutral) |
34.43 (3.15) |
-90.85% | Details | |
| 3/12/2020 | Syndax Pharmaceuticals | SNDX | Maintain | Buy (N/A) |
|
Details | ||
| 3/12/2020 | Vanda Pharmaceuticals | VNDA | Upgrade | Buy (Neutral) |
10.76 (5.95) |
-44.7% | Details | |
| 3/5/2020 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 3/5/2020 | Ionis Pharmaceuticals | IONS | New Coverage | Buy (N/A) |
50.72 (76.61) |
51.04% | Details | |
| 2/26/2020 | Amarin Corporation | AMRN | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2020 | NGM Biopharmaceuticals | NGM | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2020 | NGM Biopharmaceuticals | NGM | Maintain | Buy (N/A) |
|
Details | ||
| 2/20/2020 | PTC Therapeutics | PTCT | Downgrade | Neutral (Buy) |
58.36 (84.38) |
44.59% | Details | |
| 2/18/2020 | Amarin Corporation | AMRN | Upgrade | Buy (Neutral) |
17.69 (16.12) |
-8.88% | Details | |
| 2/14/2020 | Esperion Therapeutics | ESPR | Downgrade | Neutral (Buy) |
73.84 (3.15) |
-95.73% | Details | |
| 2/7/2020 | Millendo Therapeutics Inc. | MLND | New Coverage | Buy (N/A) |
7.72 (1.06) |
-86.27% | Details | |
| 1/2/2020 | Intercept Pharmaceuticals | ICPT | Downgrade | Neutral (Buy) |
123.44 (19.00) |
-84.61% | Details | |
| 12/26/2019 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 12/19/2019 | Minerva Neurosciences | NERV | Maintain | Buy (N/A) |
|
Details | ||
| 12/18/2019 | PhaseBio Pharmaceuticals Inc. | PHAS | Maintain | Buy (N/A) |
|
Details | ||
| 12/18/2019 | Esperion Therapeutics | ESPR | Maintain | Buy (N/A) |
|
Details | ||
| 12/17/2019 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 12/17/2019 | Mirum Pharamceuticals | MIRM | Maintain | Buy (N/A) |
|
Details | ||
| 12/16/2019 | DBV Technologies S.A | DBVT | New Coverage | Buy (N/A) |
8.55 (15.70) |
83.63% | Details | |
| 12/10/2019 | NGM Biopharmaceuticals | NGM | Maintain | Buy (N/A) |
|
Details | ||
| 12/9/2019 | X4 Pharmaceuticals | XFOR | Upgrade | Buy (Neutral) |
10.70 (4.08) |
-61.87% | Details | |
| 12/2/2019 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 11/26/2019 | The Medicines Company | MDCO | Maintain | Neutral (N/A) |
|
Details | ||
| 11/26/2019 | CymaBay Therapeutic | CBAY | Maintain | Buy (N/A) |
|
Details | ||
| 11/20/2019 | The Medicines Company | MDCO | Maintain | Neutral (N/A) |
|
Details | ||
| 11/18/2019 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 11/18/2019 | Amarin Corporation | AMRN | Downgrade | Neutral (Buy) |
24.02 (17.69) |
-26.35% | Details | |
| 11/7/2019 | Vanda Pharmaceuticals | VNDA | Downgrade | Neutral (Buy) |
13.14 (5.95) |
-54.72% | Details | |
| 11/6/2019 | Amarin Corporation | AMRN | Maintain | Buy (N/A) |
|
Details | ||
| 10/30/2019 | PTC Therapeutics | PTCT | Maintain | Buy (N/A) |
|
Details | ||
| 9/30/2019 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 9/27/2019 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 9/26/2019 | PTC Therapeutics | PTCT | Maintain | Buy (N/A) |
|
Details | ||
| 9/24/2019 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 9/17/2019 | The Medicines Company | MDCO | Downgrade | Neutral (Buy) |
48.70 (84.90) |
74.33% | Details | |
| 9/17/2019 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 9/15/2019 | Inovio Pharmaceuticals | INO | Maintain | Buy (N/A) |
|
Details | ||
| 9/4/2019 | Intercept Pharmaceuticals | ICPT | Upgrade | Buy (Neutral) |
61.37 (123.44) |
101.14% | Details | |
| 9/3/2019 | The Medicines Company | MDCO | Maintain | Buy (N/A) |
|
Details | ||
| 9/3/2019 | PTC Therapeutics | PTCT | Maintain | Buy (N/A) |
|
Details | ||
| 9/3/2019 | PhaseBio Pharmaceuticals Inc. | PHAS | Maintain | Buy (N/A) |
|
Details | ||
| 8/30/2019 | aTyr Pharma | LIFE | Maintain | Neutral (N/A) |
|
Details | ||
| 8/29/2019 | Solid Biosciences | SLDB | Downgrade | Sell (Neutral) |
8.36 (4.74) |
-43.3% | Details | |
| 8/20/2019 | Amarin Corporation | AMRN | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2019 | Mirum Pharamceuticals | MIRM | New Coverage | Buy (N/A) |
14.77 (113.76) |
670.21% | Details | |
| 8/9/2019 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 8/1/2019 | Amarin Corporation | AMRN | Maintain | Buy (N/A) |
|
Details | ||
| 8/1/2019 | Vanda Pharmaceuticals | VNDA | Upgrade | Buy (Neutral) |
12.65 (13.14) |
3.87% | Details | |
| 6/13/2019 | CymaBay Therapeutic | CBAY | Maintain | Buy (N/A) |
|
Details | ||
| 5/31/2019 | NantKwest | NK | Downgrade | Sell (Neutral) |
1.07 (32.49) |
2936.45% | Details | |
| 5/30/2019 | Intercept Pharmaceuticals | ICPT | Maintain | Neutral (Neutral) |
|
Details | ||
| 5/29/2019 | X4 Pharmaceuticals | XFOR | Maintain | Neutral (N/A) |
|
Details | ||
| 5/29/2019 | X4 Pharmaceuticals | XFOR | Maintain | Neutral (N/A) |
|
Details | ||
| 5/28/2019 | Esperion Therapeutics | ESPR | Maintain | Buy (N/A) |
|
Details | ||
| 5/24/2019 | PhaseBio Pharmaceuticals Inc. | PHAS | Maintain | Buy (N/A) |
|
Details | ||
| 5/22/2019 | aTyr Pharma | LIFE | Maintain | Neutral (N/A) |
|
Details | ||
| 5/16/2019 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 5/16/2019 | Solid Biosciences | SLDB | Maintain | Neutral (N/A) |
|
Details | ||
| 5/15/2019 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 5/15/2019 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 5/14/2019 | CymaBay Therapeutic | CBAY | New Coverage | Buy (N/A) |
13.00 (32.48) |
149.85% | Details | |
| 5/6/2019 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 5/3/2019 | PTC Therapeutics | PTCT | Maintain | Buy (N/A) |
|
Details | ||
| 5/3/2019 | PTC Therapeutics | PTCT | Maintain | Buy (N/A) |
|
Details | ||
| 5/2/2019 | Amarin Corporation | AMRN | Maintain | Buy (N/A) |
|
Details | ||
| 4/29/2019 | NGM Biopharmaceuticals | NGM | New Coverage | Buy (N/A) |
15.57 (1.54) |
-90.11% | Details | |
| 4/26/2019 | The Medicines Company | MDCO | Maintain | Buy (N/A) |
|
Details | ||
| 4/10/2019 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 4/10/2019 | The Medicines Company | MDCO | Maintain | Buy (N/A) |
|
Details | ||
| 3/26/2019 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 3/19/2019 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2019 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 2/11/2019 | NantKwest | NK | Maintain | Neutral (N/A) |
|
Details | ||
| 2/8/2019 | Solid Biosciences | SLDB | Upgrade | Neutral (Sell) |
22.34 (8.36) |
-62.58% | Details | |
| 1/8/2019 | Amarin Corporation | AMRN | Maintain | Buy (N/A) |
|
Details | ||
| 12/19/2018 | FibroGen | FGEN | Upgrade | Buy (Neutral) |
38.99 (9.71) |
-75.1% | Details | |
| 12/12/2018 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 12/3/2018 | Solid Biosciences | SLDB | Maintain | Sell (N/A) |
|
Details | ||
| 11/30/2018 | NantKwest | NK | Upgrade | Neutral (Sell) |
1.74 (1.07) |
-38.51% | Details | |
| 11/14/2018 | Amarin Corporation | AMRN | Upgrade | Buy (Neutral) |
15.38 (24.02) |
56.18% | Details | |
| 11/12/2018 | PhaseBio Pharmaceuticals Inc. | PHAS | New Coverage | Buy (N/A) |
5.01 (0.07) |
-98.6% | Details | |
| 11/6/2018 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2018 | Solid Biosciences | SLDB | New Coverage | Sell (N/A) |
34.44 (22.34) |
-35.13% | Details | |
| 11/2/2018 | Amarin Corporation | AMRN | Downgrade | Neutral (Buy) |
22.64 (15.38) |
-32.07% | Details | |
| 10/17/2018 | NantKwest | NK | Downgrade | Sell (Neutral) |
3.44 (1.74) |
-49.42% | Details | |
| 10/16/2018 | Amarin Corporation | AMRN | Maintain | Buy (N/A) |
|
Details | ||
| 10/11/2018 | Syndax Pharmaceuticals | SNDX | Maintain | Buy (N/A) |
|
Details | ||
| 9/25/2018 | Amarin Corporation | AMRN | Maintain | Buy (N/A) |
|
Details | ||
| 9/4/2018 | Madrigal Pharmaceuticals | MDGL | New Coverage | Buy (N/A) |
239.21 (517.29) |
116.25% | Details | |
| 8/17/2018 | The Medicines Company | MDCO | Maintain | Buy (N/A) |
|
Details | ||
| 8/17/2018 | aTyr Pharma | LIFE | Upgrade | Neutral (Sell) |
0.63 (17.79) |
2723.81% | Details | |
| 8/17/2018 | Esperion Therapeutics | ESPR | Upgrade | Buy (Neutral) |
45.96 (73.84) |
60.66% | Details | |
| 8/17/2018 | Arsanis Inc. | ASNS | Maintain | Neutral (N/A) |
|
Details | ||
| 8/14/2018 | Sarepta Therapeutics | SRPT | New Coverage | Buy (N/A) |
129.53 (17.16) |
-86.75% | Details |
